It’ll be a busy December for dividend growth investors, with 25 companies announcing their annual increases. Check out the ...

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1% since the end of ...

Dividend stocks remain appealing even to wealthy investors who don't rely on income. AbbVie, Johnson & Johnson, and Pfizer ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Many billionaires who definitely don't need income still have dividend stocks in their portfolios. Which dividend stocks ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

Pfizer (NYSE:PFE) discovers, develops, manufactures, markets, distributes and sells biopharmaceutical products in the United ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

Shares of Pfizer have lost about half their value since the end of 2022, but its dividend payout has been moving in the opposite direction. Last December, the pharmaceutical giant raised its ...

Pfizer has been making dividend payments for 344 consecutive quarters, and it has been one of the most stable income stocks to own in the healthcare industry. The company recently raised its ...

Such a low valuation would imply that Pfizer, an industry giant, is on the ropes. The stock's 6.7% dividend yield is the highest it's ever been outside of the financial crisis in 2008-2009.